ALSO READBSE Brokers ties up with Arab, African commerce bodies Kassa case: BSE asks clients to file arbitration in 90 days BSE to roll out 'paperless SIP' for MF investors this month BSE wants to be 'investment exchange' of country: Chauhan BSE 100 cos see 5% jump in sales in Q4 after 4 quarter decline
Resonance Specialties today said its manufacturing facility at Mandideep has been inspected by US health regulator USFDA.
One of the company's manufacturing sites -- Vista Organics Pvt, Mandideep -- has been recently inspected by the United States Food and Drug Administration (USFDA), Resonance Specialties said in a BSE filing.
"No 483 observations have been issued and Establishment Inspection Report (EIR) is awaited," it added.
EIR is given after the successful completion of the inspection by USFDA.
The stock of Resonance Specialties today closed 4.93 per cent lower at Rs 38.60 on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)